Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Onconetix ( (ONCO) ).
On December 5, 2025, Onconetix, Inc. held a meeting where the Compensation Committee approved a $45,000 bonus for Interim CEO Karina Fedasz for her 2025 service, with an additional $5,000 monthly increase in her base compensation starting January 2026. The same day, the company conducted its annual stockholders’ meeting, approving several proposals including director elections, stock issuance related to Series D and E Preferred Stock, and the appointment of MaloneBailey, LLP as the independent auditor for 2025.
Spark’s Take on ONCO Stock
According to Spark, TipRanks’ AI Analyst, ONCO is a Underperform.
Onconetix’s overall score reflects substantial financial difficulties with significant operating losses and negative profitability metrics. The technical analysis suggests a bearish trend, and the valuation metrics are unfavorable due to negative earnings. These factors combine to give the stock a low attractiveness score.
To see Spark’s full report on ONCO stock, click here.
More about Onconetix
Average Trading Volume: 114,317
Technical Sentiment Signal: Sell
Current Market Cap: $4.35M
For a thorough assessment of ONCO stock, go to TipRanks’ Stock Analysis page.